# FAPI-74 PET/CT in Adults With Fibrosis

> **NCT06413355** · PHASE1 · RECRUITING · sponsor: **Abramson Cancer Center at Penn Medicine** · enrollment: 45 (estimated)

## Conditions studied

- Fibrosis (Morphologic Abnormality)

## Interventions

- **DRUG:** [F-18]-FAPI-74

## Key facts

- **NCT ID:** NCT06413355
- **Lead sponsor:** Abramson Cancer Center at Penn Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-07-16
- **Primary completion:** 2027-07-30
- **Final completion:** 2027-07-30
- **Target enrollment:** 45 (ESTIMATED)
- **Last updated:** 2026-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06413355

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06413355, "FAPI-74 PET/CT in Adults With Fibrosis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06413355. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*